Cargando…

Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study

OBJECTIVE: Combinations of Chinese herbal products (CHPs) are widely used for ischemic heart disease (IHD) in Taiwan. We analyzed the usage and frequency of CHPs prescribed for patients with IHD. METHODS: A nationwide population-based cross-sectional study was conducted, 53531 patients from a random...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Yu-Chiang, Tseng, Ying-Jung, Hu, Wen-Long, Chen, Hsuan-Ju, Li, Tsai-Chung, Tsai, Pei-Yuan, Chen, Hsin-Ping, Huang, Meng-Hsuan, Su, Fang-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556444/
https://www.ncbi.nlm.nih.gov/pubmed/26322893
http://dx.doi.org/10.1371/journal.pone.0137058
_version_ 1782388349727670272
author Hung, Yu-Chiang
Tseng, Ying-Jung
Hu, Wen-Long
Chen, Hsuan-Ju
Li, Tsai-Chung
Tsai, Pei-Yuan
Chen, Hsin-Ping
Huang, Meng-Hsuan
Su, Fang-Yen
author_facet Hung, Yu-Chiang
Tseng, Ying-Jung
Hu, Wen-Long
Chen, Hsuan-Ju
Li, Tsai-Chung
Tsai, Pei-Yuan
Chen, Hsin-Ping
Huang, Meng-Hsuan
Su, Fang-Yen
author_sort Hung, Yu-Chiang
collection PubMed
description OBJECTIVE: Combinations of Chinese herbal products (CHPs) are widely used for ischemic heart disease (IHD) in Taiwan. We analyzed the usage and frequency of CHPs prescribed for patients with IHD. METHODS: A nationwide population-based cross-sectional study was conducted, 53531 patients from a random sample of one million in the National Health Insurance Research Database (NHIRD) from 2000 to 2010 were enrolled. Descriptive statistics, the multiple logistic regression method and Poisson regression analysis were employed to estimate the adjusted odds ratios (aORs) and adjusted risk ratios (aRRs) for utilization of CHPs. RESULTS: The mean age of traditional Chinese medicine (TCM) nonusers was significantly higher than that of TCM users. Zhi-Gan-Cao-Tang (24.85%) was the most commonly prescribed formula CHPs, followed by Xue-Fu-Zhu-Yu-Tang (16.53%) and Sheng-Mai-San (16.00%). The most commonly prescribed single CHPs were Dan Shen (29.30%), Yu Jin (7.44%), and Ge Gen (6.03%). After multivariate adjustment, patients with IHD younger than 29 years had 2.62 times higher odds to use TCM than those 60 years or older. Residents living in Central Taiwan, having hyperlipidemia or cardiac dysrhythmias also have higher odds to use TCM. On the contrary, those who were males, who had diabetes mellitus (DM), hypertension, stroke, myocardial infarction (MI) were less likely to use TCM. CONCLUSIONS: Zhi-Gan-Cao-Tang and Dan Shen are the most commonly prescribed CHPs for IHD in Taiwan. Our results should be taken into account by physicians when devising individualized therapy for IHD. Further large-scale, randomized clinical trials are warranted in order to determine the effectiveness and safety of these herbal medicines.
format Online
Article
Text
id pubmed-4556444
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45564442015-09-10 Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study Hung, Yu-Chiang Tseng, Ying-Jung Hu, Wen-Long Chen, Hsuan-Ju Li, Tsai-Chung Tsai, Pei-Yuan Chen, Hsin-Ping Huang, Meng-Hsuan Su, Fang-Yen PLoS One Research Article OBJECTIVE: Combinations of Chinese herbal products (CHPs) are widely used for ischemic heart disease (IHD) in Taiwan. We analyzed the usage and frequency of CHPs prescribed for patients with IHD. METHODS: A nationwide population-based cross-sectional study was conducted, 53531 patients from a random sample of one million in the National Health Insurance Research Database (NHIRD) from 2000 to 2010 were enrolled. Descriptive statistics, the multiple logistic regression method and Poisson regression analysis were employed to estimate the adjusted odds ratios (aORs) and adjusted risk ratios (aRRs) for utilization of CHPs. RESULTS: The mean age of traditional Chinese medicine (TCM) nonusers was significantly higher than that of TCM users. Zhi-Gan-Cao-Tang (24.85%) was the most commonly prescribed formula CHPs, followed by Xue-Fu-Zhu-Yu-Tang (16.53%) and Sheng-Mai-San (16.00%). The most commonly prescribed single CHPs were Dan Shen (29.30%), Yu Jin (7.44%), and Ge Gen (6.03%). After multivariate adjustment, patients with IHD younger than 29 years had 2.62 times higher odds to use TCM than those 60 years or older. Residents living in Central Taiwan, having hyperlipidemia or cardiac dysrhythmias also have higher odds to use TCM. On the contrary, those who were males, who had diabetes mellitus (DM), hypertension, stroke, myocardial infarction (MI) were less likely to use TCM. CONCLUSIONS: Zhi-Gan-Cao-Tang and Dan Shen are the most commonly prescribed CHPs for IHD in Taiwan. Our results should be taken into account by physicians when devising individualized therapy for IHD. Further large-scale, randomized clinical trials are warranted in order to determine the effectiveness and safety of these herbal medicines. Public Library of Science 2015-08-31 /pmc/articles/PMC4556444/ /pubmed/26322893 http://dx.doi.org/10.1371/journal.pone.0137058 Text en © 2015 Hung et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Hung, Yu-Chiang
Tseng, Ying-Jung
Hu, Wen-Long
Chen, Hsuan-Ju
Li, Tsai-Chung
Tsai, Pei-Yuan
Chen, Hsin-Ping
Huang, Meng-Hsuan
Su, Fang-Yen
Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study
title Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study
title_full Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study
title_fullStr Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study
title_full_unstemmed Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study
title_short Demographic and Prescribing Patterns of Chinese Herbal Products for Individualized Therapy for Ischemic Heart Disease in Taiwan: Population-Based Study
title_sort demographic and prescribing patterns of chinese herbal products for individualized therapy for ischemic heart disease in taiwan: population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556444/
https://www.ncbi.nlm.nih.gov/pubmed/26322893
http://dx.doi.org/10.1371/journal.pone.0137058
work_keys_str_mv AT hungyuchiang demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT tsengyingjung demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT huwenlong demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT chenhsuanju demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT litsaichung demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT tsaipeiyuan demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT chenhsinping demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT huangmenghsuan demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy
AT sufangyen demographicandprescribingpatternsofchineseherbalproductsforindividualizedtherapyforischemicheartdiseaseintaiwanpopulationbasedstudy